from Reuters: Health News https://ift.tt/2nouCkz
Tuesday, 1 October 2019
AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm
AstraZeneca Plc said on Tuesday it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.
from Reuters: Health News https://ift.tt/2nouCkz
from Reuters: Health News https://ift.tt/2nouCkz
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment